Quantum Capital Management (California)’s AtriCure ATRC Stock Holding History

Quantum Capital Management (California)’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-126,363	Closed	-$5.68M	–	230
2020 Q2	$5.68M	Hold	126,363	–	–	3.32%	6
2020 Q1	$4.25M	Hold	126,363	–	–	2.85%	7
2019 Q4	$4.11M	Hold	126,363	–	–	1.98%	8
2019 Q3	$3.15M	Buy	126,363 +6,923	+6%	+$198K	1.6%	13
2019 Q2	$3.56M	Sell	119,440 -7,595	-6%	-$222K	1.95%	7
2019 Q1	$3.4M	Buy	127,035 +845	+0.7%	+$25.7K	1.83%	15
2018 Q4	$3.86M	Sell	126,190 -28,263	-18%	-$880K	2.24%	6
2018 Q3	$5.41M	Buy	154,453 +40,108	+35%	+$1.27M	1.94%	4
2018 Q2	$3.09M	Buy	114,345 +5,458	+5%	+$128K	1.19%	19
2018 Q1	$2.23M	Buy	108,887 +30,980	+40%	+$559K	0.54%	44
2017 Q4	$1.42M	Buy	77,907 +30,817	+65%	+$610K	0.34%	60
2017 Q3	$1.05M	Buy	+47,090	New	+$1.06M	0.25%	82

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantum Capital Management (California)'s ATRC Position: Q3 2020 in Review

Quantum Capital Management (California) sold out of AtriCure (ATRC) in Q3 2020, closing a stake of 126,363 shares — an estimated $5.68M sold.

Quantum Capital Management (California) first reported a position in ATRC in Q3 2017 and held it in 12 quarters. The position peaked at $5.68M in Q2 2020. 183 funds tracked by Wall St. Rank hold ATRC as of Q3 2020.

Quantum Capital Management (California) reported no remaining AtriCure position as of Q3 2020 after selling out during the quarter.
Quantum Capital Management (California) sold 126,363 AtriCure shares in Q3 2020, an estimated $5.68M.
Quantum Capital Management (California) first reported a position in AtriCure in Q3 2017 and held it in 12 quarters.
Quantum Capital Management (California)'s AtriCure position peaked at $5.68M in Q2 2020.
183 funds tracked by Wall St. Rank held AtriCure as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.